Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | May 23, 2016 at 10:45 AM EDT

Are Nanosphere Shareholders Getting Enough With This New Offer?

Nanosphere started the week off with a bang on Monday, following an update on an acquisition offer.

Jon C. Ogg | May 23, 2016 at 8:05 AM EDT

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

Biotech is the one arena that still offers massive upside for investors — if they can pick the right companies…

Chris Lange | May 19, 2016 at 10:20 AM EDT

8 Stocks on the Move After ASCO Cancer Abstracts

ASCO has just released the abstracts for its exhibitors ahead of the conference. For investors and analysts, sometimes winners or…

Chris Lange | May 19, 2016 at 9:05 AM EDT

Could This Be the Turning Point for Tonix Pharma?

Tonix Pharmaceuticals watched its shares take a handy jump early on Thursday, following positive results from its mid-stage PTSD study.

Chris Lange | May 16, 2016 at 12:40 PM EDT

Cotiviti Announces Potential Pricing for IPO

Cotiviti expects to price more than 12 million shares in the range of $17 to $19 per share in an…

Jon C. Ogg | May 16, 2016 at 12:15 PM EDT

Janney Remains Bullish on Editas Medicine

Editas Medicine Inc. (NASDAQ: EDIT) has become a rather interesting stock for many speculative biotech and biohealth investors. It has…

Chris Lange | May 16, 2016 at 12:05 PM EDT

Reata Pharma Fills in the Blanks for Its IPO

Reata Pharmaceuticals has amended its filing with the U.S. Securities and Exchange Commission (SEC) regarding its initial public offering (IPO).

Lee Jackson | May 16, 2016 at 10:45 AM EDT

Investor Sentiment Is Horrible and Fund Outflows Are Huge: RBC Says Stay Positive

Three solid health care ideas featured by RBC are posting good numbers and expanding their product silos in an effort…

Chris Lange | May 16, 2016 at 10:25 AM EDT

Did Valeant Pharmaceuticals Capitulate Its Pricing?

Valeant Pharmaceuticals is trying to change its tune by announcing that it will offer an enhanced rebate program to all…

Chris Lange | May 16, 2016 at 9:50 AM EDT

Is This the Beginning of the End of Aduro BioTech?

Aduro BioTech has announced that the Phase 2b ECLIPSE trial did not meet the primary endpoint of an improvement in…

Paul Ausick | May 16, 2016 at 7:50 AM EDT

Pfizer Pays $5.2 Billion for Anacor

Pfizer has announced that it has reached a definitive agreement to acquire Anacor Pharmaceuticals in a deal valued at more…

Douglas A. McIntyre | May 15, 2016 at 9:00 AM EDT

Will Prilosec’s Bad New Hurt Procter & Gamble?

The heartburn drug Prilosec got a damaging blow when a study in Circulation Research showed that the class of drugs called proton pump…

Douglas A. McIntyre | May 14, 2016 at 9:10 AM EDT

Oncobiologics IPO Collapses 20%

The Oncobiologics initial public offering suffered a devastating first day. Shares ended down 20%.

Chris Lange | May 12, 2016 at 10:15 AM EDT

Parnell Pharma Gears Up for Secondary Offering

Parnell Pharmaceuticals Holdings saw its shares drop by over 10% early Thursday following the pricing of its secondary offering.

Chris Lange | May 12, 2016 at 7:40 AM EDT

ASCO Could Make or Break These 7 Cancer Drug Trials

The king of biotech and pharma events is about to take place. The 2016 annual meeting of the American Society…

1 … 210 211 212 213 214 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Are Nanosphere Shareholders Getting Enough With This New Offer?

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

8 Stocks on the Move After ASCO Cancer Abstracts

Could This Be the Turning Point for Tonix Pharma?

Cotiviti Announces Potential Pricing for IPO

Janney Remains Bullish on Editas Medicine

Reata Pharma Fills in the Blanks for Its IPO

Investor Sentiment Is Horrible and Fund Outflows Are Huge: RBC Says Stay Positive

Did Valeant Pharmaceuticals Capitulate Its Pricing?

Is This the Beginning of the End of Aduro BioTech?

Pfizer Pays $5.2 Billion for Anacor

Will Prilosec’s Bad New Hurt Procter & Gamble?

Oncobiologics IPO Collapses 20%

Parnell Pharma Gears Up for Secondary Offering

ASCO Could Make or Break These 7 Cancer Drug Trials

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Live: Navitas Semiconductor Q1 Earnings Tonight. Can the 676% Surge Survive the Print?

Health and Healthcare Articles

All Health and Healthcare Articles

Are Nanosphere Shareholders Getting Enough With This New Offer?

10 Speculative Biotech and Biohealth Stocks With Massive Analyst Upside Calls

8 Stocks on the Move After ASCO Cancer Abstracts

Could This Be the Turning Point for Tonix Pharma?

Cotiviti Announces Potential Pricing for IPO

Janney Remains Bullish on Editas Medicine

Reata Pharma Fills in the Blanks for Its IPO

Investor Sentiment Is Horrible and Fund Outflows Are Huge: RBC Says Stay Positive

Did Valeant Pharmaceuticals Capitulate Its Pricing?

Is This the Beginning of the End of Aduro BioTech?

Pfizer Pays $5.2 Billion for Anacor

Will Prilosec’s Bad New Hurt Procter & Gamble?

Oncobiologics IPO Collapses 20%

Parnell Pharma Gears Up for Secondary Offering

ASCO Could Make or Break These 7 Cancer Drug Trials

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that’s now reaching retirees’ statements

Which Big-Box Store Chain Has Dominated 2026: Walmart, Target, or Costco?

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check

Featured Reads

The DOJ just charged 324 defendants in the largest Medicare fraud takedown ever — $14.6 billion that's now reaching retirees' statements

A $360,000 Portfolio That Quietly Pays You More Than the Average Social Security Check